Germany – Postdoc in Translational Bioinformatics at German Cancer Research Center

University: German Cancer Research CenterCountry: GermanyDeadline: 2026-04-03Fields: Bioinformatics, Pharmacogenomics, Cancer Biology, Molecular Biology, Computational BiologyTopic: Germany – Postdoc in Translational Bioinformatics at German Cancer Research CenterFields: Bioinformatics, Pharmacogenomics, Cancer Biology, Molecular Biology, Computational BiologyPosition: postdocCountry: europeDeadline: 2026-04-03Main Category: life & medical sciencesUniversity: German Cancer Research CenterReal Country: Germany—Germany – Postdoc in Translational Bioinformatics at German Cancer Research CenterAre you passionate about transforming cutting-edge bioinformatics research into tangible benefits for cancer patients? Do you aspire to work at the interface of computational science and clinical application, driving forward the future of precision oncology? If so, this postdoctoral opportunity in Translational Bioinformatics and Pharmacogenomics at the German Cancer Research Center (DKFZ) could be the next step in your academic and professional journey.About The University Or Research InstituteThe German Cancer Research Center (DKFZ), located in Heidelberg, stands as one of Europe’s largest and most respected cancer research institutions. As a member of the esteemed Helmholtz Association, DKFZ is internationally recognized for its pioneering contributions to cancer research, prevention, diagnosis, and therapy. The center’s mission, “Research for a life without cancer,” unites a diverse team of world-class scientists, clinicians, and technical experts in a collaborative, interdisciplinary environment.Heidelberg itself is a renowned academic hub, home to Germany’s oldest university and a vibrant scientific community. DKFZ benefits from its close partnerships with the Heidelberg University Hospital, the University of Heidelberg, and the Thoraxklinik Heidelberg, forming the National Center for Tumor Diseases (NCT) Heidelberg. This unique collaboration fosters a dynamic setting where innovative research is rapidly translated into clinical applications, offering researchers access to state-of-the-art infrastructure, global networks, and a supportive, family-friendly environment.Germany is an attractive destination for researchers, offering high standards of living, excellent healthcare, and a strong commitment to work-life balance. International scientists are welcomed and supported through tailored programs, making it a leading choice for postdoctoral training in life and medical sciences.Research Topic and SignificanceThe position is embedded within the Molecular Precision Oncology Program at the NCT and DKFZ. The focus is on translational bioinformatics and pharmacogenomics—fields that are revolutionizing how we understand and treat cancer. By integrating high-dimensional data such as next-generation sequencing, epigenomics, and proteomics, the research aims to identify actionable genetic lesions and pharmacogenetic profiles in cancer patients.This work is vital for advancing precision medicine, where treatments are tailored to the unique genetic makeup of each patient. The ability to interpret both somatic and germline mutations in pharmacogenes enables clinicians to optimize drug therapies, minimize adverse effects, and improve patient outcomes. The impact of this research extends beyond academia, directly influencing clinical decision-making and offering hope for more effective, individualized cancer care.Project DetailsThe postdoctoral scientist will join an interdisciplinary team comprising bioinformaticians, molecular biologists, and clinicians. The core responsibilities include:– Analyzing complex, multi-omics datasets to discover targetable lesions in cancer.– Performing both germline and somatic genotyping in pharmacogene loci.– Providing clinically relevant interpretations of actionable mutations and drug metabolizer phenotypes.– Contributing to personalized treatment recommendations discussed in weekly molecular tumor boards.– Evaluating molecular biomarkers for patient inclusion in interventional clinical trials.– Participating in the development of analysis workflows and pipelines for high-dimensional data.– Working within a quality management system aiming for ISO 15189 accreditation.– Engaging in an EU-funded multinational project, with opportunities for independent research in collaboration with both dry and wet lab scientists.The position offers a competitive salary according to the TV-L scale, occupational pension, flexible and family-friendly working arrangements, and access to professional development through the DKFZ International Postdoc Program and Career Service. The initial contract is for two years, with the possibility of extension.Candidate ProfileIdeal Candidates Will Demonstrate– A completed Ph.D. (or equivalent doctorate) in bioinformatics, informatics, physics, or a closely related field.– Strong experience in the analysis of next-generation sequencing data, preferably with clinical applications.– Proficiency in interpreting actionable mutations and/or genotyping pharmacogenes.– Knowledge of cancer biology, pharmacogenomics, and drug treatment is highly advantageous.– Excellent English language skills, as English is the working language of the team.– A collaborative mindset, enthusiasm for interdisciplinary research, and a commitment to advancing cancer care through scientific innovation.Applicants should be motivated to contribute to a diverse and international research environment and eager to develop both their technical and translational skills.Application ProcessThe application deadline is 03.04.2026.Applications Must Be Submitted Online Via The Official Job Listing. E-mail Applications Cannot Be Accepted, And Applications Submitted By Post Will Not Be Returned. For Further Details And To Apply, Please Refer To The Official Advertisementhttps://www.nature.com/naturecareers/job/12856675/postdoctoral-scientist-in-translational-bioinformatics-and-pharmacogenomics/ConclusionIf you are driven to make a difference in the fight against cancer and possess the skills and ambition to excel in translational bioinformatics and pharmacogenomics, this postdoctoral position at DKFZ offers an outstanding opportunity. Join a world-class team, access unparalleled resources, and contribute to groundbreaking research that directly impacts patient care. Interested candidates are encouraged to apply and to explore similar opportunities in the vibrant scientific community of Germany.Questions & AnswersQuestion: What makes DKFZ an attractive place for postdoctoral research?DKFZ is one of Europe’s leading cancer research centers, offering access to advanced technologies, interdisciplinary teams, and strong collaborations with clinical partners. Its international environment and comprehensive career support make it ideal for postdoctoral development.Question: What is the main focus of this postdoctoral position?The position centers on translational bioinformatics and pharmacogenomics, analyzing complex genomic data to identify actionable genetic lesions and optimize personalized cancer therapies.Question: Is experience with next-generation sequencing essential?Yes, candidates should have hands-on experience analyzing next-generation sequencing data, ideally in a clinical or cancer research context.Question: How does this role contribute to patient care?The research directly informs personalized treatment recommendations, enabling more effective and targeted cancer therapies through the integration of genetic and pharmacogenomic data.Question: Are international applicants encouraged to apply?Absolutely. DKFZ values diversity and welcomes applications from talented researchers worldwide, offering support for relocation and integration.Question: What are the benefits of living and working in Germany?Germany offers a high quality of life, excellent healthcare, strong research infrastructure, and a welcoming environment for international scientists.Question: Can postdocs develop their own research projects?Yes, there are opportunities to initiate independent research in collaboration with other scientists at DKFZ.Question: What is the contract length and are extensions possible?The initial contract is for two years, with the possibility of prolongation based on performance and funding.Want to calculate your PhD admission chances? Try it here:https://phdfinder.com/2026/03/12/phd-admission-chance-calculator/We’re an independent team helping students find opportunities.Found this opportunity helpful? Support us with a coffee!Also SeeCanada – Postdoctoral Position in Pharmacogenomics at University of TorontoUK – Clinical Research Fellowship in Dementia at University College LondonComprehensive Guide to Graduate Application Deadlines for US Universities (Fall 2026 Intake)USA – Research Assistant in Clinical Neuroscience at Yale UniversityUSA – PhD/Postdoc in AI for Cancer Imaging at Harvard Medical School